drugset / Trial / NCT05725031

Intubation Conditions After RSI Using Rocuronium with Ephedrine Pretreatment

NCT05725031

Phase 3 Completed 75 enrolled Ain Shams University
RandomizedParallel-groupSingle-blindHealth-services research

Summary

This trial will study if ephedrine pretreatment before low doses of rocuronium (0.6 or 0.8 mg/kg) would provide similar intubating conditions as with the high dose of 1.2 mg/kg in patients undergoing RSII.

Timeline

Start
2023-04-01
Primary completion
2024-02-01
Completion
2024-03-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Ephedrine Small molecule 70 ug/kg
Subject Rocuronium Other / unclassified 0.6 mg/kg
Subject Rocuronium Other / unclassified 0.8 mg/kg
Subject Rocuronium Other / unclassified 1.2 mg/kg

Indications

No indication recorded.